Natixis Advisors L.P. Buys 53,229 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Natixis Advisors L.P. boosted its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 154.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 87,681 shares of the company’s stock after purchasing an additional 53,229 shares during the period. Natixis Advisors L.P.’s holdings in Acadia Healthcare were worth $6,817,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. GAMMA Investing LLC acquired a new position in shares of Acadia Healthcare in the fourth quarter valued at approximately $26,000. Headlands Technologies LLC bought a new position in shares of Acadia Healthcare during the third quarter valued at $25,000. Fifth Third Bancorp grew its stake in shares of Acadia Healthcare by 25.5% in the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock worth $52,000 after purchasing an additional 136 shares during the last quarter. DekaBank Deutsche Girozentrale acquired a new stake in Acadia Healthcare in the third quarter valued at $96,000. Finally, Oak Thistle LLC bought a new position in Acadia Healthcare during the 4th quarter worth $235,000.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on ACHC shares. Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 price target on shares of Acadia Healthcare in a research note on Tuesday, March 5th. TheStreet upgraded shares of Acadia Healthcare from a “c” rating to a “b-” rating in a report on Monday, March 4th. Mizuho reduced their price objective on shares of Acadia Healthcare from $84.00 to $70.00 and set a “neutral” rating on the stock in a research note on Friday, May 3rd. Royal Bank of Canada reiterated an “outperform” rating and set a $94.00 price objective on shares of Acadia Healthcare in a research report on Monday, March 4th. Finally, StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Friday, May 3rd. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, Acadia Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $88.89.

Acadia Healthcare Trading Up 6.7 %

NASDAQ:ACHC opened at $70.49 on Friday. The firm has a fifty day simple moving average of $75.41 and a two-hundred day simple moving average of $77.27. Acadia Healthcare Company, Inc. has a 12 month low of $64.74 and a 12 month high of $87.77. The stock has a market capitalization of $6.54 billion, a price-to-earnings ratio of -503.50, a PEG ratio of 1.96 and a beta of 1.31. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.63.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Thursday, May 2nd. The company reported $0.84 EPS for the quarter, beating the consensus estimate of $0.80 by $0.04. The company had revenue of $768.10 million during the quarter, compared to the consensus estimate of $779.20 million. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The firm’s revenue for the quarter was up 9.1% compared to the same quarter last year. During the same period last year, the business posted $0.75 EPS. Analysts expect that Acadia Healthcare Company, Inc. will post 3.56 EPS for the current fiscal year.

Insider Transactions at Acadia Healthcare

In related news, Director Wade D. Miquelon sold 2,203 shares of Acadia Healthcare stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the completion of the sale, the director now owns 46,074 shares of the company’s stock, valued at approximately $3,934,258.86. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 2.00% of the stock is owned by insiders.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.